By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Oncology
Vaccines





Company News
TapImmune Inc. (TPIV) Appoints John Bonfiglio As Strategic Advisor 2/25/2015 9:14:09 AM
TapImmune Inc. (TPIV) Appoints Patrick D. Yeramian, MD, Consulting Medical Director To Lead Phase II Clinical Trials In Triple Negative Breast And HER2/neu Breast Cancer 2/23/2015 9:31:23 AM
TapImmune Inc. (TPIV) To Present At The 3rd Annual Sachs Bio Partnering & Investment Forum On February 23, 2015 2/20/2015 1:33:28 PM
TapImmune Inc. (TPIV)'s CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" For Phase II Trials 2/12/2015 12:57:46 PM
TapImmune Inc. (TPIV) Announces $1,464,000 Million Registered Direct Offering 1/12/2015 9:27:40 AM
TapImmune Inc. (TPIV) Release: Positive Phase 1 Immune Responses In All Evaluable Ovarian And Breast Cancer Patients Advances Vaccine To Phase 2 Clinical Trials 1/12/2015 8:50:40 AM
Published Review and Analyst Report Boost TapImmune Inc. (TPIV) Shares 11/20/2014 2:37:19 PM
VGTI Florida To Collaborate With TapImmune Inc. (TPIV) To Advance Targeted Breast And Ovarian Cancer Vaccines Into Phase 2 Clinical Trials 11/19/2014 12:06:31 PM
TapImmune Inc. (TPIV) Announces Phase 2 Clinical Trials Collaboration With VGTI Florida To Advance Breast And Ovarian Cancer Vaccines 11/18/2014 10:26:08 AM
TapImmune Inc. (TPIV) Provides Update On Polystart™ Vaccine Platform Applicable To Cancer And Infectious Disease 10/22/2014 7:41:11 AM
12345678
//-->